Rankings
▼
Calendar
QTTB (Q32 Bio Inc.) Stock Financials & Earnings | Market Cap Arena
QTTB
Q32 Bio Inc.
Mkt Cap
$73M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
$30M
EPS (TTM)
$2.30
Free Cash Flow (TTM)
-$27M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
2.4x
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$3M
$3M
-$7M
Q2 23
$3M
$3M
-$7M
Q3 23
$2M
$2M
-$8M
Q4 23
-$15M
-$15M
-$26M
Q1 24
$0
-$123K
-$15M
Q2 24
$0
-$121K
-$18M
Q3 24
$0
$0
-$19M
Q4 24
$0
$0
-$15M
Q1 25
$0
$0
-$12M
Q2 25
$0
-$91K
-$9M
Q3 25
$0
$0
-$8M
Q4 25
$0
$0
$46M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
13.6x
—
Q2 23
9.4x
—
Q3 23
8.3x
—
Q4 23
—
—
Q1 24
—
—
Q2 24
—
—
Q3 24
—
—
Q4 24
—
—
Q1 25
—
—
Q2 25
—
—
Q3 25
—
—
Q4 25
—
2.4x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$12M
-$13M
Q2 23
$2M
$2M
Q3 23
$16M
$16M
Q4 23
-$11M
-$11M
Q1 24
-$15M
-$15M
Q2 24
-$22M
-$22M
Q3 24
-$20M
-$20M
Q4 24
-$11M
-$11M
Q1 25
-$12M
-$12M
Q2 25
-$11M
-$11M
Q3 25
-$4M
-$4M
Q4 25
$0
$0
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$5K
Q2 23
$224K
Q3 23
$1K
Q4 23
$0
Q1 24
$0
Q2 24
$15K
Q3 24
$58K
Q4 24
$2K
Q1 25
$0
Q2 25
$0
Q3 25
$0
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+267.5%
-73.1%
Q2 23
+299.6%
-64.0%
Q3 23
+131.8%
-71.3%
Q4 23
-1928.2%
-68.4%
Q1 24
-100.0%
+43.8%
Q2 24
-100.0%
+71.0%
Q3 24
-100.0%
+94.8%
Q4 24
+100.0%
+30.3%
Q1 25
—
-17.6%
Q2 25
—
-48.8%
Q3 25
—
-59.7%
Q4 25
—
-415.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$296K
10.0%
Q2 23
$0
0.0%
Q3 23
$301K
16.2%
Q4 23
$0
—
Q1 24
$417K
—
Q2 24
$1M
—
Q3 24
$1M
—
Q4 24
$1M
—
Q1 25
$1M
—
Q2 25
$1M
—
Q3 25
$1M
—
Q4 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$8M
—
$2M
Q2 23
$8M
—
$2M
Q3 23
$7M
—
$2M
Q4 23
$8M
$3M
—
Q1 24
$10M
—
$5M
Q2 24
$13M
$5M
—
Q3 24
$14M
$4M
—
Q4 24
$11M
$4M
—
Q1 25
$7M
$5M
—
Q2 25
$5M
$4M
—
Q3 25
$4M
—
$4M
Q4 25
$3M
$5M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$34M
$141M
$175M
Q1 23
$39M
$111M
$150M
Q2 23
$77M
$50M
$127M
Q3 23
$36M
$0
$36M
Q4 23
$26M
$0
$26M
Q1 24
$116M
$20M
$135M
Q2 24
$98M
$10M
$108M
Q3 24
$89M
$0
$89M
Q4 24
$78M
$0
$78M
Q1 25
$65M
$0
$65M
Q2 25
$55M
$0
$55M
Q3 25
$49M
$0
$49M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
3M
+0.4%
Q2 23
3M
+0.1%
Q3 23
3M
+0.1%
Q4 23
3M
+0.3%
Q1 24
12M
+270.5%
Q2 24
12M
+0.2%
Q3 24
12M
+0.9%
Q4 24
12M
+1.0%
Q1 25
12M
+0.0%
Q2 25
12M
+0.0%
Q3 25
12M
+0.4%
Q4 25
13M
+2.9%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 16
—
—
FY 17
—
—
FY 18
$43K
124
FY 19
$9K
187
FY 20
$13K
205
FY 21
$152K
224
FY 22
$72K
92
FY 23
-$950K
7
FY 24
$0
42
FY 25
$0
200K
marketcaparena.com